PMID- 23255885
OWN - NLM
STAT- PubMed-not-MEDLINE
LR  - 20220316
IS  - 1792-1074 (Print)
IS  - 1792-1082 (Electronic)
IS  - 1792-1074 (Linking)
VI  - 5
IP  - 1
DP  - 2013 Jan
TI  - Updates on the cytogenetics and molecular cytogenetics of benign and intermediate 
      soft tissue tumors.
PG  - 12-18
AB  - SOFT TISSUE TUMORS ARE CLASSIFIED ACCORDING TO THEIR HISTOLOGICAL RESEMBLANCE TO 
      NORMAL ADULT TISSUES AND CAN BE GROUPED INTO THE FOLLOWING CATEGORIES BASED ON 
      METASTATIC POTENTIAL: benign, intermediate (locally aggressive), intermediate 
      (rarely metastasizing) and malignant. Over the past two decades, considerable 
      progress has been made in our understanding of the genetic background of soft 
      tissue tumors. Traditional laboratory techniques, such as cytogenetic analysis 
      and fluorescence in situ hybridization (FISH), can be used for diagnostic 
      purposes in soft tissue pathology practice. Moreover, cytogenetic and molecular 
      studies are often necessary for prognostics and follow-up of soft tissue sarcoma 
      patients. This review provides updated information on the applicability of 
      laboratory genetic testing in the diagnosis of benign and intermediate soft 
      tissue tumors. These tumors include nodular fasciitis, chondroid lipoma, 
      collagenous fibroma (desmoplastic fibroblastoma), giant cell tumor of tendon 
      sheath (GCTTS)/pigmented villonodular synovitis (PVNS), angiofibroma of soft 
      tissue, myxoinflammatory fibroblastic sarcoma (MIFS) and ossifying fibromyxoid 
      tumor (OFMT).
FAU - Nishio, Jun
AU  - Nishio J
AD  - Department of Orthopaedic Surgery, Faculty of Medicine, Fukuoka University, 
      Fukuoka 814-0180, Japan.
LA  - eng
PT  - Journal Article
DEP - 20121030
PL  - Greece
TA  - Oncol Lett
JT  - Oncology letters
JID - 101531236
PMC - PMC3525488
EDAT- 2012/12/21 06:00
MHDA- 2012/12/21 06:01
PMCR- 2012/10/30
CRDT- 2012/12/21 06:00
PHST- 2012/09/10 00:00 [received]
PHST- 2012/10/04 00:00 [accepted]
PHST- 2012/12/21 06:00 [entrez]
PHST- 2012/12/21 06:00 [pubmed]
PHST- 2012/12/21 06:01 [medline]
PHST- 2012/10/30 00:00 [pmc-release]
AID - ol-05-01-0012 [pii]
AID - 10.3892/ol.2012.1002 [doi]
PST - ppublish
SO  - Oncol Lett. 2013 Jan;5(1):12-18. doi: 10.3892/ol.2012.1002. Epub 2012 Oct 30.